Intensity Therapeutics, Inc. (NASDAQ:INTS)周五获得Brookline Capital Markets给予的买入评级,目标价设定为$15.00。该公司因开发一种新型的肿瘤内药物递送技术而备受关注,这种技术在治疗实体瘤方面显示出巨大潜力。 Intensity Therapeutics的方法旨在直接靶向肿瘤,导致癌细胞死亡并刺激免疫反应。该公司报告称,已完成的试 ...
SFC Markets and Finance: The government is launching future investment projects under the "Ignite Thailand" plan, related to this the Securities Commission of Thailand (SEC) recently launched a ...